Titlebook: Basis and Treatment of Cardiac Arrhythmias; Robert E. Kass,Colleen E. Clancy Book 2006 Springer-Verlag Berlin Heidelberg 2006 cardiac arrh

agitate

Pacemaker Current and Automatic Rhythms: Toward a Molecular Understanding,ily, best fits these criteria. The biophysical and molecular characteristics of this current are reviewed, and progress to date in developing selective pharmacologic agents targeting . . and in using gene and cell-based therapies to modulate the current are reviewed.

GLARE

hERG Trafficking and Pharmacological Rescue of LQTS-2 Mutant Channels,he numbers of hERG channels at the membrane. Some trafficking-defective mutants can be rescued by pharmacological agents or temperature. Here we review evidence for rescue of mutant hERG subunits expressed in heterologous systems and discuss the potential for therapeutic approaches to correcting . . defects associated with LQTS.

nitric-oxide

Mutation-Specific Pharmacology of the Long QT Syndrome,eview, we summarize some of the key clinical and genetic characteristics of this disease and highlight novel findings about ion channel structure, function, and the causal relationship between channel dysfunction and human disease, that have come from investigations of this disorder.

Commodious

landfill

tendinitis

concentrate

https://doi.org/10.1007/3-540-29715-4cardiac arrhythmias; ion channels; mechanisms of arrhythmia; molecular targets; tissue; treatment of arrh

Cirrhosis

Prostaglandins

Grating

Handbook of Experimental Pharmacologyhttp://image.papertrans.cn/b/image/181290.jpg